loading

The Problem, Economic Impact

MetaboAI targets a large and growing market at the intersection of AI, chronic disease management, and preventive healthcare. With a scalable, data-driven platform and clear revenue paths through subscriptions, partnerships, and clinical programs, MetaboAI is positioned for strong margins, recurring revenue, and long-term growth.

Diabetes Is a Cost Crisis

  • In the U.S., over 38 million adults live with diabetes, roughly 1 in 10.
  • 537 million adults worldwide live with diabetes today
  • Projected to reach 643 million by 2030
  • Investor insight: This is not a niche market. It is one of the largest and fastest-growing chronic health segments globally.

    • timelines
    38 M

    $412 Billion in Annual U.S. Healthcare Costs

  • Diabetes costs the U.S. $412B per year
  • $306B in direct medical costs
  • $106B in lost productivity
  • Average person with diabetes spends 2.3× more on healthcare than someone without
  • Investor insight: Even modest improvements in glucose control represent enormous cost-savings potential for payers, employers, and individuals.

    • timelines
    $412 B

    Most Complications Are Preventable

    5–10% A1C reduction significantly lower risk of:

  • Cardiovascular disease
  • Kidney failure
  • Neuropathy and amputations
  • Yet most patients receive reactive care, not daily guidance
  • Investor insight: Prevention and behavior-change tools remain under-served, creating a clear opportunity for AI-driven, low-cost intervention.

    • timelines
    5-10%

    MetaboAI Targets the Gap

  • Daily decision support, not episodic care
  • Turns CGM and habit data into simple, actionable steps
  • Focused on early intervention, consistency, and habit formation
  • Potential healthcare savings of $1,000–$4,000 per user per year.
  • Investor insight: MetaboAI sits at the intersection of AI, chronic care, and preventive health, addressing a multi-hundred-billion-dollar problem with scalable software.

    • timelines
    $4000


    The solution, MetaboAI

    MetaboAI is an AI-powered conversational coach trained on diabetes education and lifestyle guidance. It helps users interpret glucose trends and convert them into practical actions.

    Real-time coaching
    • Contextual suggestions based on meals, exercise, sleep, stress, and routine.
    • Forecast potential spikes and dips to support better decisions before they happen.
    • Designed to integrate with CGMs and wearables (Dexcom, Libre, Apple Health, Google Fit).
    Predictive Habit Change
    • Forecast potential spikes and dips to support better decisions before they happen.
    • Behavioral nudges and structured routines for sustainable improvement.
    • Optional reporting to support coordinated care and shared accountability.
    • Built with HIPAA/GDPR-aligned principles and a privacy-first mindset.
    Why now
    • CGM adoption is expanding beyond diabetes into broader metabolic health and wellness.
    • Insurers and payers are investing in digital diabetes solutions and outcomes-driven programs.
    • The market is moving from tracking apps to actionable, AI-driven coaching.

    Why we win
    • Predictive insights, not just historical tracking
    • Designed for real-world behavior, not clinical dashboards
    • Positioned at the intersection of AI, CGMs, and habit change
    • Healthcare is moving from reactive care to proactive prevention
    • Consumers expect continuous, intelligent guidance—not static reports
    Market opportunity
    • Global digital diabetes management market projected to reach tens of billions by 2030 (as cited in the deck).
    • TAM: ~$22B–$40B by 2030, SAM: ~$8B–$12B, SOM: ~$150M–$300M focused on early adopters using CGMs.
    • MetaboAI is positioned to bridge the gap between clinical CGM apps and everyday wellness needs.
    Business model
    • Freemium with premium tiers (example range: $9–$19/month).
    • Insurers, clinics, employers, and diabetes education partners.
    • Aligned with payer priorities: engagement, cost containment, and measurable outcomes.
    • Strategic partnerships with food and CGM ecosystems

    Traction, Roadmap
    • Mobile app build (iOS and Android)
    • Dexcom integration and data ingestion
    • Pattern engine and coaching modules
    • Meal analysis (GI/GL) and vision-enabled input
    • AI orchestration with guardrails
    • Data preparation for model training
    • Train proprietary MetaboAI model
    • Apple Health and Google Fit integrations
    • Expanded metabolic health modules beyond diabetes
    Investment opportunity
    • Seed fundraising round currently open
    • Attractive early-stage valuation
    • Clear growth plan toward next financing milestone
    • Full MVP plus predictive AI engine
    • Seamless CGM integrations with Dexcom and Libre
    • HIPAA readiness and compliance path
    • Beta launch and early traction
    Use of funds
    • Product development and tech: 45%
    • Regulatory and compliance: 15%
    • Marketing and growth: 25%
    • Operations and team: 10%
    • Contingency: 5%


    protfolio
    LET'S TALK
    Discuss investment opportunity
    and partnerships

    Interested in the investment opportunity? Fill out the form or schedule a meeting.







    vector
    Explore the Investment Opportunity

    Connect with MetaboAI to learn more about our vision, product, and growth strategy as we build the future of AI-driven metabolic health.

    Call +1 310-913-3953 OR
    svg-imageMake Appointment
    svg-imageMake Appointment